Parkinson Disease (PD) Clinical Trials

32 recruitingLast updated: June 18, 2026

There are 32 actively recruiting parkinson disease (pd) clinical trials across 16 countries. Studies span Not Applicable, Phase 1, Phase 2. Top locations include Shanghai, Shanghai Municipality, China, San Francisco, California, United States, Newcastle upon Tyne, United Kingdom. Updated daily from ClinicalTrials.gov.


Parkinson Disease (PD) Trials at a Glance

32 actively recruiting trials for parkinson disease (pd) are listed on ClinicalTrialsFinder across 6 cities in 16 countries. The largest study group is Not Applicable with 19 trials, with the heaviest enrollment activity in Shanghai, San Francisco, and Newcastle upon Tyne. Lead sponsors running parkinson disease (pd) studies include Northumbria University, Annemette Lokkegaard, and Ankara University.

Browse parkinson disease (pd) trials by phase

Treatments under study

About Parkinson Disease (PD) Clinical Trials

Looking for clinical trials for Parkinson Disease (PD)? There are currently 31 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Parkinson Disease (PD) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Parkinson Disease (PD) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 32 trials

Recruiting
Not Applicable

Adaptive DBS for PD RCT

Parkinson Disease (PD)
Beijing Pins Medical Co., Ltd60 enrolled9 locationsNCT07635823
Recruiting
Phase 2

D-SPARK: A Clinical Trial of D-Serine for Modifying Parkinson's Disease Progression

Parkinson's DiseaseParkinson Disease (PD)
Haukeland University Hospital100 enrolled11 locationsNCT07312110
Recruiting
Not Applicable

Effects of Dual-Task Training on Upper Extremity Function in Parkinson's Disease

Parkinson Disease (PD)
Ankara University38 enrolled1 locationNCT07536542
Recruiting
Not Applicable

Developing Precision Microbiota-Based Cocktail Modification Therapy to Delay the Progression of Parkinson's Disease (PD) - Use Preclinical Human Trials to Confirm the Impact of the Optimal "Probiotic Y7, Tryptophan and Branched-chain Amino Acid" Cocktail Formula on Early Stage PD Patients

Gut MicrobiotaParkinson Disease (PD)Probiotic
Taipei Medical University120 enrolled1 locationNCT07619560
Recruiting
Not Applicable

Effects of Transcutaneous Vagus Nerve Stimulation in Parkinson´s Disease

Parkinson Disease (PD)Transcutaneous Vagal Nerve Stimulation (tVNS)
Universidade da Coruña46 enrolled1 locationNCT07588191
Recruiting
Not Applicable

Robot-Assisted Gait Training vs NMES in Parkinson's Disease

Parkinson Disease (PD)
Kanuni Sultan Suleyman Training and Research Hospital40 enrolled1 locationNCT07589296
Recruiting
Not Applicable

Changes in Movement, Fitness, and Quality of Life in People With Parkinson's Disease After Different Exercise Programs

Parkinson Disease (PD)
University of Texas, El Paso45 enrolled2 locationsNCT07221266
Recruiting
Phase 1

Safety and Feasibility of Bilateral Striatal Transplantation of DopaCell in Parkinson's Disease

Parkinson Disease (PD)
Royan Institute10 enrolled1 locationNCT07572071
Recruiting
Not Applicable

Exercise Management in Parkinson's Disease

Parkinson Disease (PD)
Marmara University30 enrolled1 locationNCT07302386
Recruiting
Not Applicable

Effect of Motor Imagery Added to Rehabilitation on Balance and Kinesiophobia in Patients With Parkinson's Disease

Parkinson Disease (PD)
Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital42 enrolled1 locationNCT07495462
Recruiting
Phase 2

18F-mFBG Cardiac Uptake With Lewy Body Dementia

Lewy Body Dementia (LBD)Parkinson Disease (PD)
Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)20 enrolled1 locationNCT07176286
Recruiting
Not Applicable

Rehabilitation With Dual-task Exercises to Improve Balance in Patients With Parkinson's Disease

Parkinson Disease (PD), Postural Balance
G. d'Annunzio University74 enrolled1 locationNCT07013214
Recruiting
Not Applicable

Motor and Cognitive Exercise in Parkinson's Disease.

Parkinson Disease (PD)
Annemette Lokkegaard48 enrolled1 locationNCT07465107
Recruiting

Validation of α-synuclein Modifications in Parkinson's dIsoRder Evolution

Parkinson Disease (PD)
Casa di Cura IGEA1,200 enrolled4 locationsNCT06941012
Recruiting

Objective Mobility Assessment Using Wearable Technology for Clinical Application in Parkinson's Disease: From Validation to Fall Prediction

Parkinson Disease (PD)
Northumbria University60 enrolled1 locationNCT07281755
Recruiting

Clinical Validity of the DANU Sports System for Gait and Balance Assessment in Parkinson's Disease

Parkinson Disease (PD)Healthy (Controls)
Northumbria University60 enrolled2 locationsNCT07281794
Recruiting
Not Applicable

Effects of Transcranial Direct Current Stimulation Combined With Nordic Walking on Gait and Balance in Parkinson's Disease

Gait DisordersParkinson Disease (PD)Postural Balance
Universidade Metodista de Piracicaba40 enrolled1 locationNCT07381907
Recruiting

The Ultrasonographic Evaluation of Abdominal Accessory Respiratory Muscle Thickness in Patients With Parkinson's Disease: Correlation With Disease Severity and Expiratory Respiratory Muscle Strength

Parkinson Disease (PD)Maximum Inspiratory PressureMaximum Expiratory Pressure+1 more
Istanbul Physical Medicine Rehabilitation Training and Research Hospital36 enrolled1 locationNCT07308795
Recruiting
Phase 1Phase 2

Clinical Study to Evaluate XS411 in Treatment of Early-onset Parkinson's Disease

Parkinson Disease (PD)
XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd.90 enrolled1 locationNCT07166757
Recruiting
Not Applicable

Safety and Usability of the Cionic Neural Sleeve for Parkinson's Disease

Parkinson Disease (PD)
Cionic, Inc.10 enrolled2 locationsNCT07284823